Allied Market Research
Fabry’s Disease Treatment Market

Fabry’s Disease Treatment Market: Global Opportunity Analysis and Industry Forecast, 2023-2030 Market

Report Code: A11241
Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.


Fabry’s Disease or alpha galactosidase-A deficiency is a rare inherited disorder, as a result of the buildup of particular type of fat, namely globotriaosylceramide inside the body’s cells. It is initiated during childhood, and also shows signs and symptoms, which affects various parts of the human body. The characteristic sign or symptom that is shown by the individual includes the formation of clusters of small, dark red colored spots on the skin surface called as angiokeratomas, concurrent episodes of pain in hands and feet namely acroparasthesias, reduced ability to sweat causing hypohidrosis, and impairment in hearing or hearing loss. Furthermore, the symptoms include problems in the gastrointestinal system, formation of cloudiness or streaks in front part of the eye called as corneal verticillata, and continuous ringing in the ear called as tinnitus. It also induces potentially life threatening complications such as heart attack, kidney problems, and also stroke. The rise in number of the incidences of Fabry’s Disease will help the industry grow in the coming years.

COVID-19 scenario analysis:

Pharmaceutical and biotechnological companies are collaborating with governments, around the globe and are working to address the COVID-19 outbreak, from assisting in the development of vaccines to planning for medicines supply chain challenges. The researchers have innovated around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, the medications such as Hydroxychloroquine have been witnessing dramatic surge in demand for the management of COVID-19. Such increase in the demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Due to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the forecast period.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The increase in R&D of the treatment for Fabry’s disease would help the industry grow in the coming years. Furthermore, the additional benefits given for the drugs which are orphan drugs include tax benefits offered by the government for clinical testing and exemption from the prescription medication fees would boost the market in the near future. Additionally, the researcher or the market leader gets exclusivity for distribution of the medication until patent expires. The supervision over the orphan drugs being strict due to the usage of the therapy over specific population affected from the disease and lesser number of approved drugs due to the associated risks of the complications would help the key leaders gain maximum shares during the forecast period. Moreover, the lesser susceptibility on the approval of the drugs after humongous amount of investment may hinder the growth of the market in the coming years.

The global Fabry’s Disease Treatment market trends are as follows:

New product launches to boost the market

The surge in the product launches for the Fabry’s Disease Treatment will gain attention of the global population toward the awareness of such diseases, thereby propelling the industrial growth. The key leaders are focusing mainly over the research and development of the products for medication of Fabry’s Disease, which is anticipated to help the industry grow during the forecast period. For instance, in July 2019, Takeda launched a new enzyme replacement therapy portfolio for the disorders such as Lysosomal Storage Disorders (LSD), to help the individuals with rare diseases in India. The product launched for Fabry’s Disease was Agalsidase alfa. The market leaders are using strategic planning by focusing on specific region and hence capturing maximum shares in the industry.

Furthermore, the strategic planning adopted by the key leaders include the addition of divisions made especially for R&D of the products which are useful for the cure of rare diseases. For instance, Chielsi in February 2020, launched a separate division for the innovation in the curative medication of the Lysosomal Storage Disorders, which also includes Fabry’s Disease. The increase in the advancement in the medication and its positive results would help the industry grow in the near future.

Longer period of royalty for research will flourish the market

The disease being rare is supervised and surveillance reports are closely checked and reported to the government organizations. The Fabry’s Disease is to be given a therapy of the medication called orphan drugs. These medications are given to restricted patient population having limited approval as drugs, on the basis of the toxicity level and side effects being clinically tested. Furthermore, added benefits are provided to the orphan drugs, due to years of R&D owing to the total spending being very high. These drugs are provided with market exclusivity; also an exclusion from prescription drug fees and government also gives tax benefits for the clinical testing of the drugs.

There is a huge investment in R&D of such rare diseases, and approval of the drugs is also difficult even after clinical trials are carried out. The royalty or the exclusivity is hence an advantage for the key market players and hence is anticipated to boost the industry during the forecast period.

Key benefits of the report:

  • This study presents the analytical depiction of the global Fabry’s Disease treatment industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Fabry’s disease treatment market share.
  • The current market is quantitatively analyzed to highlight the global Fabry’s disease treatment market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global Fabry’s disease treatment market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Fabry’s disease treatment market research report:

  • Which are the leading market players active in the Fabry’s disease treatment market?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

Fabry’s Disease Treatment Market: Global Opportunity Analysis and Industry Forecast, 2020–2027 Report Highlights

Aspects Details
By Distribution Channel
  • E-commerce
  • Drug Store and Pharmacies
  • Others
By Medication
  • Agalsidase beta
  • Agalsidase Alpha
  • Migalstat
  • Antihistamines
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Rest of LAMEA)
Key Market Players ISU ABXIS, Genzyme Corporation, Idorsia Pharmaceuticals Ltd, AVROBIO, Inc., Biosidus S.A., Shire, Neuraltus Pharmaceuticals, Inc.., Amicus Therapeutics, Inc., JCR Pharmaceuticals Co., Ltd., Protalix

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Purchase Options

Call or Email Us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Fabry’s Disease Treatment Market

Start reading.
This Report and over 71,229+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690  $3,321
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820  $4,947
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540  $5,559
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870  $7,896
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Related Reports
*Terms and Conditions Apply

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time for readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save the time of readers